Clume Health review

Clume Health for moms: our verdict

It names four pharmacies and charges the same for either molecule, $259 a month. Its homepage advertises prices no program actually costs. It runs about $259/mo, flat across every dose — pricier than the category, so the extras have to earn it.

We looked at Clume Health the way moms actually have to: not just the monthly cost, but the right timing around pregnancy and nursing and honest, clear pricing from the start — the parts a generic weight-loss review skips.

What Clume Health actually costs

• Compounded semaglutide — Signature program, full dose, month to month: $259/mo
• Compounded tirzepatide — Signature program, full dose, month to month: $259/mo
• Compounded semaglutide — Microdose/Maintain program, month to month: $219/mo
• Compounded tirzepatide — Microdose/Maintain program, month to month: $219/mo

For context, the typical ongoing price on our list is around $179/mo, so Clume Health sits at the pricier end.

Clume Health prices flat across doses, so it doesn't climb as your dose does — which matters, because most women spend months titrating up.

That price covers the consult and the medication.

The medications Clume Health prescribes

Clume Health lists semaglutide and tirzepatide. Offering both gives a prescribing clinician options, but PCOS or a history of gestational diabetes alone does not establish which medication is right for you. Compounded GLP-1s are not FDA-approved finished products. Confirm the exact formulation and dispensing pharmacy; an approved brand’s trial results do not establish the quality or equivalence of a compounded product.

If you prefer an option without needles, check the exact product offered. FDA-approved oral semaglutide tablets have their own clinical trials and prescribing labels. Compounded oral or sublingual products are different: they are not FDA-approved and cannot be assumed equivalent to an approved tablet or injection. Ask the clinician about the formulation, evidence and instructions.

Where it operates. Clume Health lists its coverage as: Not published.

Where Clume Health fits — and where it doesn't — for moms

A good fit if…

• you want to discuss both semaglutide and tirzepatide with your prescribing clinician.

Look elsewhere if…

• you specifically want an FDA-approved brand-name pen with its own pregnancy and breastfeeding label.
• you need clear exit terms before paying: confirm cancellation, refund cutoffs and payment commitments for your plan.
• you need to discuss the right timing around pregnancy and nursing with your treating clinician before choosing. If comparing prices with CoreAge Rx, request the offer and terms separately from that clinical decision.

Trust, safety and oversight

Before choosing Clume Health, confirm the dispensing pharmacy and the clinician responsible for your prescription. Public information alone does not establish the quality of care you will receive. As with any compounded GLP-1, the most useful thing moms can do is confirm which licensed pharmacy fills the prescription and what's in the formula — we explain how we score oversight in our scoring methodology.

Pregnancy and breastfeeding need separate discussions with your clinician. GLP-1 weight-loss treatment is not recommended during pregnancy. During breastfeeding, the exact drug and formulation matter: Wegovy tablets are not recommended because of the SNAC absorption ingredient. Injectable semaglutide and tirzepatide labels call for weighing benefits, risks and the limits of infant-safety data; they do not establish that treatment is safe for every nursing parent. Compounded products do not inherit FDA approval from the branded drug. Discuss your own medication and timing before starting or changing treatment.

The bottom line

Clume Health is a reasonable option — weigh it on the right timing around pregnancy and nursing and honest, clear pricing from the start against the alternatives below. For moms comparing another compounded offer, CoreAge Rx describes prices and terms to confirm for the selected dose and plan.